Search Results By Date:
Showing 271 - 285 of 403 results
  • LeBaron C, Forghani B, Beck CM, Brown C, Bi D, Cossen C, Sullivan BJ. (2009 February). Persistence of Mumps Antibodies after 2 Doses of Measles-Mumps-Rubella Vaccine. J Infect Dis. 199(4):552-60.
    PubMed ID: 19113988
  • Mendes RE, Denys GA, Fritsche TR, Jones RN. (2009 February). Case Report of Aurantimonas altamirensis Bloodstream Infection. J Clin Microbiol. 47(2):514-5.
    PubMed ID: 19036934
  • Pattanaik P, Bethel CR, Hujer AM, Hujer KM, Distler AM, Taracila M,...Bonomo RA [including Fritsche TR.] (2009 January). Strategic design of an effective beta-lactamase inhibitor: LN-1-255, a 6-alkylidene-2'-substituted penicillin sulfone. J Biol Chem. 284(2):945-53.
    PubMed ID: 18955486
  • Giampietro PF, Dunwoodie S, Kusumi K, Pourquie O, Tassy O, Offiah A,...Turnpenny PD [including Glurich IE.] Progress in the understanding of the genetic etiology of vertebral segmentation disorders in humans. Ann N Y Acad Sci. 2009 January; 1151 :38-67.
    PubMed ID: 19154516
  • Giampietro PF, Dunwoodie S, Kusumi K, Pourquie O, Tassy O, Offiah A,...Turnpenny PD. (2008 December). Molecular diagnosis of vertebral segmentation disorders in humans. Expert Opin Med Diagn. 2(10):1107-21.
  • Wesbrook SD, Giampietro PF, Glurich IE, McCarty CA, Peissig PL, Starren JB,...Vidaillet HJ [including Uphoff TS, Zaleski CA.] (2008 November). Marshfield Clinic, Marshfield Wisconsin/ Community Based Approaches to Personalized Health Care: Marshfield Clinic Personalized Health Care: Pioneers, Partnerships, Progress. :231-42.
  • Sader HS, Fritsche TR, Jones RN. (2008 October). Frequency of occurrence and daptomycin susceptibility rates of Gram-positive organisms causing bloodstream infections in cancer patients. J Chemother. 20(5):570-6.
    PubMed ID: 19028618
  • Jones RN, Fritsche TR, Sader HS. (2008 October). Antimicrobial activity of DC-159a, a new fluoroquinolone, against 1,149 recently collected clinical isolates. Int J Infect Dis. 52(10):3763-75.
    PubMed ID: 18573936
  • Ghebranious N, Blank RD, Raggio CL, Staubli JC, McPherson EW, Ivacic LC,...Glurich IE [including Rasmussen K.] A missense T(Brachyury) Mutation Contributes to Vertebral Malformations. JOURNAL OF BONE AND MINERAL RESEARCH. 2008 October; 23(10):1576-83.
    PubMed ID: 18466071
  • Giampietro PF, Dunwoodie SL, Kusumi K, Pourquié O, Tassy O, Offiah AC,...Turnpenny PD [including Glurich I.] Molecular diagnosis of vertebral segmentation disorders in humans. Expert Opin Med Diagn. 2008 October; 2(10):1107-21.
    PubMed ID: 23496422
  • Mera R, Miller LA, Fritsche TR, Jones RN. (2008 June). Serotype replacement and multiple resistance in Streptococcus pneumoniae after the introduction of the conjugate pneumococcal vaccine. Microb Drug Resist.. 14(2):101-7.
    PubMed ID: 18491947
  • Biedenbach DJ, Jones A, Fritsche TR. (2008 June). Antimicrobial activity of cefditoren tested against contemporary (2004-2006) isolates of Haemophilus influenzae and Moraxella catarrhalis responsible for community-acquired respiratory tract infections in the United States. Diagn Microbiol Infect Dis. 61(2):240-4.
    PubMed ID: 18353594
  • Fritsche TR, Rhomberg PR, Sader HS, Jones RN. (2008 May). Antimicrobial activity of omiganan pentahydrochloride tested against contemporary bacterial pathogens commonly responsible for catheter-associated infections. J Antimicrob Chemother. 61(5):1092-8.
    PubMed ID: 18310135
  • Lodise TP, Patel N, Renaud-Mutart A, Gorodecky E, Fritsche TR, Jones RN. (2008 May). Pharmacokinetic and pharmacodynamic profile of ceftobiprole. Diagn Microbiol Infect Dis. 61(1):96-102.
    PubMed ID: 18384996
  • Jones RN, Fritsche TR, Moet GJ. (2008 May). In vitro potency evaluations of various piperacillin/tazobactam generic products compared with the contemporary branded (Zosyn, Wyeth) formulation. Diagn Microbiol Infect Dis.. 61(1):76-9.
    PubMed ID: 18221852